Literature DB >> 25962539

[Bovine herpesvirus 4 (BoHV-4): general aspects of the biology and status in Argentina].

Pedro E Morán1, Sandra E Pérez2, Anselmo C Odeón3, Andrea E Verna3.   

Abstract

Bovine herpesvirus 4 (BoHV-4) has been isolated from cattle with respiratory infections, vulvovaginitis, mastitis, abortions, endometritis and from apparently healthy animals throughout the world. Although it has not yet been established as causal agent of a specific disease entity, it is primarily associated with reproductive disorders of cattle. This virus can infect a wide range of species, either in vivo or in vitro. Two groups of prototype strains were originated from the first isolates: the DN599-type strains (American group) and the Movar-type strains (European group). In Argentina, BoHV-4 was isolated and characterized in 2007 from vaginal discharge samples taken from cows that had aborted. So far, more than 40 isolates, mainly associated with aborting bovine females have been registered in our country.
Copyright © 2014 Asociación Argentina de Microbiología. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Biological properties; Bovine herpesvirus 4; Herpesvirus bovino 4; Propiedades biológicas; Reproductive disease; Trastornos reproductivos

Mesh:

Substances:

Year:  2015        PMID: 25962539     DOI: 10.1016/j.ram.2015.02.007

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  2 in total

1.  Assessment of replication of bovine herpesvirus type 4 in human glioblastoma and breast cancer cells as a potential oncolytic virus.

Authors:  Touraj Aligholipour Farzani; Seval Bilge Dagalp; Aykut Ozkul; Hakan Gurdal; Firat Dogan; Feray Alkan
Journal:  Virus Genes       Date:  2020-10-26       Impact factor: 2.332

2.  Isolation and characterization of bovine herpes virus 5 (BoHV5) from cattle in India.

Authors:  Naveen Kumar; Yogesh Chander; Thachamvally Riyesh; Nitin Khandelwal; Ram Kumar; Harish Kumar; Bhupendra N Tripathi; Sanjay Barua
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.